CLS HOLDINGS USA, INC. (OTCMKTS:CLSH) Files An 8-K Financial Statements and ExhibitsItem 9.01 of Form8-K, which was omitted from the Initial Form8-K in reliance on Items 9.01(a)(4)and 9.01(b)(2)of Form8-K. This Current Report on Form8-K/A should be read in conjunction with the Initial Form8-K. Except as set forth herein, no other modifications have been made to the Initial Form8-K.
Item 9.01 Financial Statements and Exhibits.
(a)Financial Statements of Businesses Acquired.
The audited consolidated statements of financial condition of Alternative Solutions as of December 31, 2017 and 2016, and the related consolidated statements of operations, consolidated statement of changes in partners’ capital, and consolidated statements of cash flows for the years ended December 31, 2017 and 2016, and the footnotes thereto, are attached hereto as Exhibit 99.1 and are incorporated herein by reference.
The unaudited condensed consolidated statements of financial condition of Alternative Solutions for the six months ended June 30, 2018, and the related condensed consolidated statements of operations and the condensed consolidated statements of cash flows for the six months ended June 30, 2018 and June 30, 2017, and the footnotes thereto, are attached hereto as Exhibit 99.2 and incorporated herein by reference.
(b)Pro Forma Financial Information.
The unaudited pro forma consolidated financial information of the Company and Alternative Solutions as of May 31, 2018 and May 31, 2017, are attached hereto as Exhibit 99.3 and are incorporated herein by reference.
(d)Exhibits.
CLS Holdings USA, Inc. ExhibitEX-99.1 2 ex_123750.htm EXHIBIT 99.1 ex_123750.htm Exhibit 99.1 ALTERNATIVE SOLUTIONS L.L.C. (A Nevada Corporation) CONSOLIDATED FINANCIAL STATEMENTS For the Years Ended December 31,…To view the full exhibit click here
About CLS HOLDINGS USA, INC. (OTCMKTS:CLSH)
CLS Holdings USA, Inc., is engaged in developing a method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates. The Company’s concentrates include oils, waxes, edibles and shatter. These concentrates may be ingested in various ways, including through vaporization through electronic cigarettes (e-cigarettes), and used for a range of pharmaceutical and other purposes. The Company intends to monetize extraction method through the licensing of its methods and processes to others, as in the Colorado Arrangement; the processing of cannabis for others, and the purchase of cannabis and the processing and sale of cannabis-related products. The Company’s products and services include Licensing Operations, Processing Revenue, Processing Facilities and Sale of Products and Brand Creation. As of May 31, 2016, the Company had not generated any revenues.
